Safety of hydrofluoroalkane-134a beclomethasone dipropionate extrafine aerosol.
Herein we assess the safety of an inhaled formulation of beclomethasone dipropionate (BDP) which uses the propellant hydrofluoroalkane-134a (HFA) for the treatment of asthma. Acute local tolerability (as assessed by the incidence of cough and mean forced expiratory volume after 1 s inhalation) was s...
| Main Authors: | , , , , |
|---|---|
| Format: | Conference item |
| Published: |
1998
|